Equities research analysts predict that Lantheus Holdings Inc (NASDAQ:LNTH) will post earnings of $0.16 per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Lantheus’ earnings. The highest EPS estimate is $0.20 and the lowest is $0.11. Lantheus reported earnings per share of $0.18 in the same quarter last year, which would suggest a negative year-over-year growth rate of 11.1%. The business is expected to announce its next earnings results after the market closes on Monday, February 26th.
On average, analysts expect that Lantheus will report full year earnings of $1.05 per share for the current financial year. For the next financial year, analysts anticipate that the company will report earnings of $1.29 per share, with EPS estimates ranging from $1.19 to $1.38. Zacks’ EPS calculations are an average based on a survey of analysts that follow Lantheus.
Several analysts have recently commented on the stock. BidaskClub downgraded shares of Lantheus from a “buy” rating to a “hold” rating in a report on Thursday, February 8th. ValuEngine upgraded shares of Lantheus from a “hold” rating to a “buy” rating in a report on Saturday, February 3rd. Finally, Zacks Investment Research downgraded shares of Lantheus from a “buy” rating to a “hold” rating in a report on Tuesday, January 30th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Lantheus presently has an average rating of “Buy” and an average price target of $24.75.
Shares of Lantheus (NASDAQ LNTH) traded up $0.20 during mid-day trading on Friday, hitting $20.55. 131,409 shares of the stock traded hands, compared to its average volume of 289,850. The stock has a market capitalization of $763.25, a P/E ratio of 25.37, a P/E/G ratio of 1.32 and a beta of 0.95. The company has a debt-to-equity ratio of -3.41, a quick ratio of 2.46 and a current ratio of 2.96. Lantheus has a 52 week low of $9.00 and a 52 week high of $24.45.
In related news, CFO John W. Crowley sold 3,866 shares of the stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $23.52, for a total transaction of $90,928.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Michael P. Duffy sold 21,655 shares of the stock in a transaction dated Wednesday, January 10th. The shares were sold at an average price of $22.40, for a total transaction of $485,072.00. Following the transaction, the insider now owns 156,784 shares of the company’s stock, valued at approximately $3,511,961.60. The disclosure for this sale can be found here. 2.30% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of LNTH. California State Teachers Retirement System boosted its position in Lantheus by 5.2% during the third quarter. California State Teachers Retirement System now owns 48,609 shares of the medical equipment provider’s stock worth $865,000 after purchasing an additional 2,409 shares during the period. Rhumbline Advisers boosted its position in Lantheus by 5.0% during the third quarter. Rhumbline Advisers now owns 53,702 shares of the medical equipment provider’s stock worth $956,000 after purchasing an additional 2,560 shares during the period. New York State Teachers Retirement System boosted its position in Lantheus by 13.4% during the third quarter. New York State Teachers Retirement System now owns 23,713 shares of the medical equipment provider’s stock worth $422,000 after purchasing an additional 2,800 shares during the period. LS Investment Advisors LLC boosted its position in Lantheus by 47.1% during the third quarter. LS Investment Advisors LLC now owns 9,306 shares of the medical equipment provider’s stock worth $166,000 after purchasing an additional 2,981 shares during the period. Finally, American International Group Inc. boosted its position in Lantheus by 14.7% during the fourth quarter. American International Group Inc. now owns 24,147 shares of the medical equipment provider’s stock worth $494,000 after purchasing an additional 3,101 shares during the period. Institutional investors own 91.08% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Lantheus Holdings Inc (LNTH) Expected to Announce Earnings of $0.16 Per Share” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/17/lantheus-holdings-inc-lnth-expected-to-announce-earnings-of-0-16-per-share.html.
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Get a free copy of the Zacks research report on Lantheus (LNTH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.